Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers.

by Gaudensia Mutua, Eduard Sanders, Peter Mugo, Omu Anzala, Jessica E Haberer, David Bangsberg, Burc Barin, James F Rooney, David Mark, Paramesh Chetty, Patricia Fast, Frances H Priddy
Published 2012-01-01

Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscord...

by Freddie M Kibengo, Eugene Ruzagira, David Katende, Agnes N Bwanika, Ubaldo Bahemuka, Jessica E Haberer, David R Bangsberg, Burc Barin, James F Rooney, David Mark, Paramesh Chetty, Patricia Fast, Anatoli Kamali, Frances H Priddy
Published 2013-01-01

In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide.

by Lisa C Rohan, Bernard J Moncla, Ratiya Pamela Kunjara Na Ayudhya, Marilyn Cost, Yunda Huang, Fang Gai, Nicole Billitto, J D Lynam, Kara Pryke, Phillip Graebing, Nicole Hopkins, James F Rooney, David Friend, Charlene S Dezzutti
Published 2010-02-01

Safety and Pharmacokinetics of a Tenofovir Alafenamide Fumarate-Emtricitabine based Oral Antiretroviral Regimen for Prevention of HIV Acquisition in Women: A Randomized Controlled...

by Andrea R. Thurman, MD, Jill L. Schwartz, MD, Mackenzie L. Cottrell, PharmD, Vivian Brache, Lic, Beatrice A. Chen, MD, MPH, Leila Cochón, Lic, Susan Ju, BA, Ian McGowan, MD PhD, James F. Rooney, MD, Scott McCallister, MD, Gustavo F. Doncel, MD PhD
Published 2021-06-01

Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant

by Fernanda P. Pons-Faudoa, Nicola Di Trani, Antons Sizovs, Kathryn A. Shelton, Zoha Momin, Lane R. Bushman, Jiaqiong Xu, Dorothy E. Lewis, Sandra Demaria, Trevor Hawkins, James F. Rooney, Mark A. Marzinke, Jason T. Kimata, Peter L. Anderson, Pramod N. Nehete, Roberto C. Arduino, K. Jagannadha Sastry, Alessandro Grattoni
Published 2020-10-01

Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings.

by Thomas B Campbell, Laura M Smeaton, N Kumarasamy, Timothy Flanigan, Karin L Klingman, Cynthia Firnhaber, Beatriz Grinsztejn, Mina C Hosseinipour, Johnstone Kumwenda, Umesh Lalloo, Cynthia Riviere, Jorge Sanchez, Marineide Melo, Khuanchai Supparatpinyo, Srikanth Tripathy, Ana I Martinez, Apsara Nair, Ann Walawander, Laura Moran, Yun Chen, Wendy Snowden, James F Rooney, Jonathan Uy, Robert T Schooley, Victor De Gruttola, James Gita Hakim, PEARLS study team of the ACTG
Published 2012-01-01